✦ LIBER ✦

302 Equal prognosis of elderly and non-elderly patients with metastatic colorectal cancer and 5-FU treatment: a retrospective analysis

✍ Scribed by G. Folprecht; W. Scheithauer; D. Cunningham; F. Di Costanzo; B. Glimellus; E. Aranda; P. Rougier; M. Palmer; J. Wils; C. Köhne

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment outcomes of oxaliplatin, 5-FU,

✍ Hee Yeon Seo; Dae Sik Kim; Yoon Seok Choi; Hwa Jung Sung; Kyong Hwa Park; In Keu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 290 KB

Influence of comorbidity, age and perfor

✍ Jehn, C.F.; Böning, L.; Kröning, H.; Pezzutto, A.; Lüftner, D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Bevacizumab plus FOLFIRI or FOLFOX as th

✍ Byung Woog Kang; Tae Won Kim; Jae-Lyun Lee; Min-Hee Ryu; Heung Moon Chang; Chang 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 188 KB

Bevacizumab is equally effective and no

✍ Price, T. J.; Zannino, D.; Wilson, K.; Simes, R. J.; Cassidy, J.; Van Hazel, G. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 238 KB

815 Elderly patients (pts) with unresect

✍ U. Gatzemeier; F. De Marinis; C. Manegold; P. Mali; L. Portalone; O. Castelnau; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

P.39 Docetaxel plus epirubicin (DE) vs d

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB